Risk factors and features of the cell-phagocytic link of immune system in mild bronchial asthma

Author:

Barabash E. Y.1,Gvozdenko T. A.1ORCID,Antonyuk M. V.1ORCID,Khodosova K. K.1,Sysoeva Yu. G.1

Affiliation:

1. Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment

Abstract

Introduction. The study of risk factors, defects of cellular and phagocytic links of the immune system with differing degrees of asthma control allows us to determine the features of chronic inflammation and predict the course of the disease. Aim. To assess risk factors and establish the severity of immunological disorders according to the state of the cellular and phagocytic links of the immune system in partially controlled mild asthma. Materials and methods. The study included 184 patients (aged 25 to 50 years) with diagnosed mild asthma, 125 of them with partially controlled course (main group), 59 patients with controlled asthma (comparison group). Risk factors were identified in all patients. CD3+, CD3+CD4+, CD3+CD8+, CD16+CD56+, CD3+CD19+ were determined by flow cytofluorimetry. The phagocytic link was evaluated based on the phagocytic activity of neutrophils, phagocytic reserve, phagocytic number, phagocytic number reserve, metabolic activity of neutrophils, neutrophil activation index and its reserve. The control group consisted of 17 healthy volunteers who did not have chronic respiratory diseases. Results. In patients with partially controlled asthma, allergic pathology of extrapulmonary localization was 3.8 times more common, foci of chronic infection were 2 times more common, and chronic herpes virus infection was 2.2 times more common. In case of partially controlled asthma, there was an increase in CD3+4+ lymphocytes by 16% (p<0.001), CD3+4+/CD3+8+ index by 1.2 times (p<0.05), a decrease in CD16+56+ by 19.6%, and CD3+8+ cells by 19.5% (p<0.001) as compared to patients with controlled asthma. Disturbance of the functional and potential capabilities of phagocytic cells was characterized by a decrease in the phagocytic number by 26.5%, the HCT test by 1.4 times (p<0.001). Conclusion. Factors hindering the achievement of control in partially controlled mild asthma may be concomitant allergic diseases, chronic herpes virus infection, a characteristic imbalance of cellular and phagocytic immunity. 

Publisher

Far Eastern Scientific Center Of Physiology and Pathology of Respiration

Subject

General Medicine

Reference19 articles.

1. Avdeev S.N., Aisanov Z.R., Arkhipov V.V., Belevskiy A.S., Vizel A.A. , Demko I.V., Emelianov A.V., Ilina N.I., Kurbacheva O.M., Leschenko I.V., Nenasheva N.M., Ovcharenko S.I., and Fassakhov R.S. on behalf of expert group. [The principles of the treatment of mild asthma: consistent guidelines of the Russian Association of Allergology and CLinical Immunology and the Russian Respiratory Society]. Prakticheskaya pul'monologiya 2017; (1):82−92 (in Russian).

2. Bystritskaya E.V., Bilichenko T.N. [The review of the bronchial asthma morbidity in the population of the Russian federation]. Pul'monologiya 2022; 32(5):651−660 (in Russian). https://doi.org/10.18093/0869-0189-2022-32-5-651-660

3. Brodskaya O.N., Belevskiy A.S. [Action plan for asthma exacerbation]. Prakticheskaya pul'monologiya 2018; (2):100−104 (in Russian).

4. Zakharova I.A., Belevskiy A.S. [The possibilities of treatment of viral-induced asthma]. Prakticheskaya pul'monologiya 2017; (3):3−6 (in Russian).

5. Konishcheva A.Yu., Gervazieva V.B. [Pathogenetic features of chronic herpesviral infection in patients with bronchial asthma]. Allergologiya i immunologiya 2017; 18(1):29−32 (in Russian).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3